Brief: Trevi Therapeutics Provides Strategic Updates Ahead Of Annual Lifesci Partners Corporate Access Event
08/01/2026 12:57
Jan 8 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS PROVIDES STRATEGIC UPDATES AHEAD OF ANNUAL LIFESCI PARTNERS CORPORATE ACCESS EVENT HELD DURING THE J.P. MORGAN HEALTHCARE CONFERENCE TREVI THERAPEUTICS INC - FDA END-OF-PHASE 2 MEETING SCHEDULED FOR Q1 2026 TREVI THERAPEUTICS INC - PHASE 2B REFRACTORY CHRONIC COUGH TRIAL TO START IN H1 2026 Source text: ID:nPn6wmY2Pa Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million